A Study to Evaluate Lumasiran in Patients With Advanced Primary Hyperoxaluria Type 1
Status:
Active, not recruiting
Trial end date:
2025-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy, safety, pharmacokinetics (PK), and
pharmacodynamics (PD) of lumasiran in patients with Advanced Primary Hyperoxaluria Type 1
(PH1).